Articles & publications

Freedom of Information and Coronavirus

Automatically translated. Read the original

Today (5 March 2021), Bloomberg reported that federal inspectors last year found repeated quality-control violations at a Pfizer Inc. plant in Kansas that the company intends to use to boost Covid-19 vaccine production for the US vaccination effort. Food and Drug Administration inspectors visited the McPherson, Kansas plant from late 2019 through January 2020. An inspection report obtained by Bloomberg through a freedom-of-information request found that the pharmaceutical giant supplied medicines without adequately investigating quality issues raised in routine checks. Findings included mold and bacteria.

https://www.bloomberg.com/news/articles/2021-03-04/pfizer-plant-helping-boost-vaccines-has-repeat-quality-offenses

In Israel, the Freedom of Information Order (Units in the Prime Minister’s Office to Which the Law Does Not Apply) excludes the Israel Institute for Biological Research, associated with research into a coronavirus vaccine, from the Freedom of Information Law.

Coronavirus is not a “security secret,” so it seems time to amend the legislation to cover this institute too.